Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice

Detalles Bibliográficos
Autores principales: Xu, Wenxin, Kage, Karen, Marcus, Warren D, Newman, Robby, Alter, Sarah, Rhode, Peter R, Wong, Hing C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649497/
http://dx.doi.org/10.1186/2051-1426-3-S2-P348
_version_ 1782401371130036224
author Xu, Wenxin
Kage, Karen
Marcus, Warren D
Newman, Robby
Alter, Sarah
Rhode, Peter R
Wong, Hing C
author_facet Xu, Wenxin
Kage, Karen
Marcus, Warren D
Newman, Robby
Alter, Sarah
Rhode, Peter R
Wong, Hing C
author_sort Xu, Wenxin
collection PubMed
description
format Online
Article
Text
id pubmed-4649497
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-46494972015-11-24 Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice Xu, Wenxin Kage, Karen Marcus, Warren D Newman, Robby Alter, Sarah Rhode, Peter R Wong, Hing C J Immunother Cancer Poster Presentation BioMed Central 2015-11-04 /pmc/articles/PMC4649497/ http://dx.doi.org/10.1186/2051-1426-3-S2-P348 Text en Copyright © 2015 Xu et al. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Poster Presentation
Xu, Wenxin
Kage, Karen
Marcus, Warren D
Newman, Robby
Alter, Sarah
Rhode, Peter R
Wong, Hing C
Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
title Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
title_full Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
title_fullStr Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
title_full_unstemmed Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
title_short Enhanced efficacy of ALT-803, an IL-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
title_sort enhanced efficacy of alt-803, an il-15-based superagonist complex, in combination with immune checkpoint inhibitors in an orthotopic muscle invasive bladder tumor model in mice
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649497/
http://dx.doi.org/10.1186/2051-1426-3-S2-P348
work_keys_str_mv AT xuwenxin enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice
AT kagekaren enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice
AT marcuswarrend enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice
AT newmanrobby enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice
AT altersarah enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice
AT rhodepeterr enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice
AT wonghingc enhancedefficacyofalt803anil15basedsuperagonistcomplexincombinationwithimmunecheckpointinhibitorsinanorthotopicmuscleinvasivebladdertumormodelinmice

Ejemplares similares